Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.
Activation of inflammatory cells is central to the pathogenesis of autoimmune demyelinating diseases of the peripheral nervous system. The novel chimeric compound quinpramine--generated from imipramine and quinacrine--redistributes cholesterol rich membrane domains to intracellular compartments. We...
Main Authors: | Gerd Meyer zu Hörste, Anne K Mausberg, Johanna I Müller, Helmar C Lehmann, Stefan Löber, Peter Gmeiner, Hans-Peter Hartung, Olaf Stüve, Carsten Korth, Bernd C Kieseier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21698177/?tool=EBI |
Similar Items
-
Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages.
by: Anne K Mausberg, et al.
Published: (2011-01-01) -
Review: Pathogenesis and treatment of immune-mediated neuropathies
by: Helmar C. Lehmann, et al.
Published: (2009-07-01) -
Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis
by: Anne K. Mausberg, et al.
Published: (2018-08-01) -
Novel pathomechanisms in inflammatory neuropathies
by: David Schafflick, et al.
Published: (2017-11-01) -
Atacicept: targeting B cells in multiple sclerosis
by: Hans-Peter Hartung, et al.
Published: (2010-07-01)